Back to Our Science

Evolution of the Nebuliser – Daniel Lock


Release date:22/10/2021


Daniel Lock, Specialist – Pharmaceutical Development shares his insights on the evolution of nebulisers, and how advancements in technology can improve patient care and inhaled product development. In this episode, Dan discusses how smart nebulisers can improve lung deposition for inhaled therapies, provide valuable patient data in clinical trials, and expand the profile of patients who may benefit from nebulised treatment.

You can follow our podcast at or subscribe it on Spotify, Apple or Google Podcasts.

If you want more information about Vectura’s differentiated capabilities please get in touch with us.

    Our podcast in your inbox

    Don't miss out on future publications by signing up to receive updates on our science

    Back to Our Science